查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1963642

临床前影像市场：全球产业分析、规模、份额、成长、趋势和预测（2025-2032）

Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5个工作天内

价格
简介目录

主要发现：

  • 临床前影像市场规模（2025年预测）：45亿美元
  • 预计市场规模（2032年）：62亿美元
  • 全球市场成长率（2025年至2032年复合年增长率）：4.6%

临床前影像市场研究范围：

临床前影像技术在生物医学研究中发挥着至关重要的作用，它能够以非侵入性的方式可视化动物模型中的生物过程。这些成像技术广泛应用于药物发现、疾病研究和转化研究，使研究人员能够即时监测疾病进展并评估治疗效果。临床前影像市场的目标客户包括製药公司、生物技术公司、研究机构和合约研究组织（CRO），并提供多种影像方式，包括光学影像、磁振造影（MRI）、电脑断层扫描（CT）、正子断层扫描（PET）和超音波系统。市场成长的驱动因素包括药物研发投入的增加、慢性病盛行率的上升以及多模态成像技术的进步，这些进步提高了研究的准确性和效率。

市场成长驱动因素：

全球临床前成像市场受多种关键因素驱动，其中包括药物发现和开发领域对先进成像工具日益增长的需求。製药和生物技术产业研发活动的不断增加，正在加速体内影像系统在疾病机制和治疗反应研究中的应用。慢性病盛行率的上升进一步增加了对有效临床前研究模式的需求。混合成像系统和基于人工智慧的影像分析等技术进步，能够实现更全面的数据收集和更优的研究成果，从而支持市场成长。此外，受託研究机构（CRO）的扩张也推动了临床前影像服务外包的增加，进一步刺激了市场需求。

市场限制：

儘管临床前成像市场前景广阔，但仍面临设备成本高和操作复杂等挑战。诸如磁振造影（MRI）和正子断层扫描（PET）等先进影像系统需要大量的资金投入和专业知识，这限制了小规模研究机构对其的采用。与动物实验相关的监管要求和伦理问题也阻碍了市场扩张。此外，成像系统的维护成本以及对操作人员的专业要求也构成了额外的障碍，尤其是在研究基础设施有限的发展中地区。

市场机会：

临床前影像市场在技术创新和研究应用拓展的推动下，蕴藏着巨大的成长机会。人工智慧 (AI) 与机器学习技术与影像分析的融合，能够提升资料解读能力，加速药物研发进程。结合解剖成像和功能成像的多模态成像系统的开发，为深入了解生物过程提供了更全面的视角。新兴市场由于研发投入的增加和製药业的蓬勃发展，展现出巨大的成长潜力。预计未来几年，研究机构与产业参与者之间的策略合作将推动创新，并协助市场扩张。

本报告解答的关键问题：

  • 推动全球临床前影像市场成长的关键因素有哪些？
  • 哪些影像技术和应用正在推动科学研究领域的应用？
  • 技术进步如何改变临床前影像市场的竞争格局？
  • 哪些是临床前影像市场的主要参与者？他们正在采取哪些策略来维持其市场地位？
  • 全球临床前影像市场有哪些新兴趋势与未来前景？

目录

第一章执行摘要

第二章 市场概览

  • 市场范围和定义
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
  • 新冠疫情影响分析
  • 预测因子－相关性和影响

第三章 加值见解

  • 产品导入分析
  • 监管状态
  • 价值链分析
  • 重大交易和合併
  • PESTLE分析
  • 波特五力分析

第四章 定价分析，2024年

  • 主要亮点
  • 影响产品价格的关键因素
  • 产品价格分析
  • 区域价格和产品偏好

第五章 全球临床前影像市场展望

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模和年成长率
    • 绝对商机
  • 市场规模分析与预测
    • 2019年至2024年市场规模表现的历史分析
    • 市场规模分析及预测（2025-2032年）
  • 全球临床前影像市场展望：产品
    • 引言/主要发现
    • 2019-2024年按产品分類的市场规模、表现及销售量（单位）分析
    • 市场规模及销售量（单位）分析及预测（依产品划分），2025-2032 年
      • 影像系统
      • 试剂
      • 软体和服务
    • 产品市场吸引力分析
  • 全球临床前影像市场按影像方式展望
    • 引言/主要发现
    • 依治疗方式分類的市场规模表现分析，2019-2024 年
    • 依治疗方式分類的市场规模分析及预测（2025-2032年）
      • 光学成像
      • 核分子影像
      • 微型磁振造影
      • 微超音波
      • 微型CT
      • 光声成像（PAT）
      • 磁粒子成像
      • 其他的
    • 按模式分類的市场吸引力分析
  • 全球临床前成像市场展望（按应用领域划分）
    • 引言/主要发现
    • 按应用领域分類的市场规模绩效分析（2019-2024 年）
    • 按应用领域分類的市场规模分析与预测（2025-2032年）
      • 研究与开发
      • 药物发现与开发
    • 按应用领域进行市场吸引力分析
  • 全球临床前成像市场展望（按最终用户划分）
    • 引言/主要发现
    • 按最终用户分類的市场规模绩效分析，2019-2024 年
    • 依最终用户分類的市场规模分析及预测（2025-2032 年）
      • 製药和生物技术公司
      • 学术和研究机构
      • 诊断影像中心
      • 其他的
    • 最终用户市场吸引力分析

6. 全球临床前影像市场区域展望

  • 主要亮点
  • 2019年至2024年各地区市场规模表现分析
  • 市场规模分析及预测（依地区划分，2025-2032年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分類的市场吸引力分析

7. 北美临床前影像市场展望

8. 欧洲临床前影像市场展望

9. 东亚临床前影像市场展望

10. 南亚和大洋洲临床前影像市场展望

11. 拉丁美洲临床前影像市场展望

12. 中东和非洲临床前影像市场展望

第十三章 竞争格局

  • 2024年市占率分析
  • 市场结构
    • 市场竞争格局分析
    • 竞争对手仪錶板
  • 公司简介（详情 - 概述、财务状况、策略、近期发展）
    • Bruker
    • Siemens Healthcare Private Limited
    • Revvity
    • FUJIFILM VisualSonics, Inc.
    • Scintica
    • MILabs BV
    • United Imaging Healthcare Co., Ltd.
    • Mediso Ltd.
    • Aspect Imaging Ltd.
    • Inviscan Imaging Systems
    • TriFoil Imaging
    • Southern Scientific Ltd.
    • Iconeus
    • MR Solutions
    • BioPAL, Inc.
    • Viscover

第十四章附录

简介目录
Product Code: PMRREP34717

Persistence Market Research has recently released a comprehensive report on the worldwide market for preclinical imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global preclinical imaging market from 2025 to 2032.

Key Insights:

  • Preclinical Imaging Market Size (2025E): USD 4.5 Billion
  • Projected Market Value (2032F): USD 6.2 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Preclinical Imaging Market - Report Scope:

Preclinical imaging plays a crucial role in biomedical research by enabling non-invasive visualization of biological processes in animal models. These imaging technologies are widely used in drug discovery, disease research, and translational studies, allowing researchers to monitor disease progression and evaluate therapeutic responses in real time. The preclinical imaging market caters to pharmaceutical and biotechnology companies, research institutions, and contract research organizations, offering a range of imaging modalities such as optical imaging, MRI, CT, PET, and ultrasound systems. Market growth is driven by increasing investments in pharmaceutical research, rising prevalence of chronic diseases, and advancements in multimodal imaging technologies that improve research accuracy and efficiency.

Market Growth Drivers:

The global preclinical imaging market is propelled by several key factors, including the growing demand for advanced imaging tools in drug discovery and development. Increasing research and development activities in pharmaceutical and biotechnology industries have accelerated the adoption of in vivo imaging systems for studying disease mechanisms and therapeutic responses. The rising prevalence of chronic diseases has further increased the need for effective preclinical research models. Technological advancements, including hybrid imaging systems and AI-powered image analysis, enable more comprehensive data acquisition and improved research outcomes, supporting market growth. Additionally, the expansion of contract research organizations contributes to increased outsourcing of preclinical imaging services, further driving market demand.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces challenges related to high equipment costs and operational complexity. Advanced imaging systems such as MRI and PET scanners require significant capital investment and specialized expertise, limiting adoption among smaller research facilities. Regulatory requirements and ethical concerns related to animal testing also present challenges for market expansion. Furthermore, maintenance costs and the need for skilled professionals to operate imaging systems create additional barriers, particularly in developing regions with limited research infrastructure.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by technological innovations and expanding research applications. The integration of artificial intelligence and machine learning in imaging analysis enhances data interpretation and accelerates drug discovery processes. The development of multimodal imaging systems that combine anatomical and functional imaging capabilities provides comprehensive insights into biological processes. Emerging markets offer substantial growth potential due to increasing research investments and expanding pharmaceutical industries. Strategic collaborations between research institutions and industry players are expected to foster innovation and support market expansion in the coming years.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the preclinical imaging market globally?
  • Which imaging modalities and applications are driving adoption across research settings?
  • How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
  • Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global preclinical imaging market focus on technological innovation, product development, and strategic collaborations to strengthen their market position. Companies invest in advanced imaging solutions, including multimodal and high-resolution imaging systems, to meet evolving research requirements. Partnerships with pharmaceutical companies and research institutions facilitate product adoption and expand market reach. Emphasis on software integration and AI-powered analytics further enhances imaging efficiency and research outcomes, enabling companies to maintain competitiveness in a rapidly evolving market landscape.

Key Companies Profiled:

  • Bruker
  • Siemens Healthcare Private Limited
  • Revvity
  • FUJIFILM VisualSonics, Inc.
  • Scintica
  • MILabs B.V.
  • Mediso Ltd.
  • Aspect Imaging Ltd.
  • MR Solutions
  • TriFoil Imaging
  • United Imaging Healthcare Co., Ltd.
  • BioPAL, Inc.

Preclinical Imaging Market Research Segmentation:

By Product:

  • Imaging Systems
  • Reagents
  • Software
  • Services

By Modality:

  • Optical Imaging
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Ultrasound Imaging
  • Others

By Application:

  • Drug Discovery and Development
  • Oncology Research
  • Neurology Research
  • Cardiology Research
  • Inflammation and Infectious Disease Research
  • Others

By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preclinical Imaging Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Preclinical Imaging Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2024
    • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Preclinical Imaging Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2024
    • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Imaging Systems
      • 5.3.3.2. Reagents
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Preclinical Imaging Market Outlook: Modality
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019 - 2024
    • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.4.3.1. Optical Imaging
      • 5.4.3.2. Nuclear Molecular Imaging
      • 5.4.3.3. Micro MRI
      • 5.4.3.4. Micro Ultrasound
      • 5.4.3.5. Micro CT
      • 5.4.3.6. Photoacoustic Tomography (PAT)
      • 5.4.3.7. Magnetic Particle Imaging
      • 5.4.3.8. Others
    • 5.4.4. Market Attractiveness Analysis: Modality
  • 5.5. Global Preclinical Imaging Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2024
    • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 5.5.3.1. Research & Development
      • 5.5.3.2. Drug Discovery & Development
    • 5.5.4. Market Attractiveness Analysis: Application
  • 5.6. Global Preclinical Imaging Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2024
    • 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 5.6.3.1. Pharmaceutical and Biotech Companies
      • 5.6.3.2. Academic and Research Institutes
      • 5.6.3.3. Imaging Centers
      • 5.6.3.4. Others
    • 5.6.4. Market Attractiveness Analysis: End User

6. Global Preclinical Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2024
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Modality
    • 7.2.4. By Application
    • 7.2.5. By End User
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Imaging Systems
    • 7.4.2. Reagents
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. Optical Imaging
    • 7.5.2. Nuclear Molecular Imaging
    • 7.5.3. Micro MRI
    • 7.5.4. Micro Ultrasound
    • 7.5.5. Micro CT
    • 7.5.6. Photoacoustic Tomography (PAT)
    • 7.5.7. Magnetic Particle Imaging
    • 7.5.8. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Research & Development
    • 7.6.2. Drug Discovery & Development
  • 7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Pharmaceutical and Biotech Companies
    • 7.7.2. Academic and Research Institutes
    • 7.7.3. Imaging Centers
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Modality
    • 8.2.4. By Application
    • 8.2.5. By End User
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Imaging Systems
    • 8.4.2. Reagents
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. Optical Imaging
    • 8.5.2. Nuclear Molecular Imaging
    • 8.5.3. Micro MRI
    • 8.5.4. Micro Ultrasound
    • 8.5.5. Micro CT
    • 8.5.6. Photoacoustic Tomography (PAT)
    • 8.5.7. Magnetic Particle Imaging
    • 8.5.8. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Research & Development
    • 8.6.2. Drug Discovery & Development
  • 8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Pharmaceutical and Biotech Companies
    • 8.7.2. Academic and Research Institutes
    • 8.7.3. Imaging Centers
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Modality
    • 9.2.4. By Application
    • 9.2.5. By End User
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Imaging Systems
    • 9.4.2. Reagents
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. Optical Imaging
    • 9.5.2. Nuclear Molecular Imaging
    • 9.5.3. Micro MRI
    • 9.5.4. Micro Ultrasound
    • 9.5.5. Micro CT
    • 9.5.6. Photoacoustic Tomography (PAT)
    • 9.5.7. Magnetic Particle Imaging
    • 9.5.8. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Research & Development
    • 9.6.2. Drug Discovery & Development
  • 9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Pharmaceutical and Biotech Companies
    • 9.7.2. Academic and Research Institutes
    • 9.7.3. Imaging Centers
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Modality
    • 10.2.4. By Application
    • 10.2.5. By End User
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Imaging Systems
    • 10.4.2. Reagents
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. Optical Imaging
    • 10.5.2. Nuclear Molecular Imaging
    • 10.5.3. Micro MRI
    • 10.5.4. Micro Ultrasound
    • 10.5.5. Micro CT
    • 10.5.6. Photoacoustic Tomography (PAT)
    • 10.5.7. Magnetic Particle Imaging
    • 10.5.8. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Research & Development
    • 10.6.2. Drug Discovery & Development
  • 10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Pharmaceutical and Biotech Companies
    • 10.7.2. Academic and Research Institutes
    • 10.7.3. Imaging Centers
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Modality
    • 11.2.4. By Application
    • 11.2.5. By End User
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Imaging Systems
    • 11.4.2. Reagents
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. Optical Imaging
    • 11.5.2. Nuclear Molecular Imaging
    • 11.5.3. Micro MRI
    • 11.5.4. Micro Ultrasound
    • 11.5.5. Micro CT
    • 11.5.6. Photoacoustic Tomography (PAT)
    • 11.5.7. Magnetic Particle Imaging
    • 11.5.8. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Research & Development
    • 11.6.2. Drug Discovery & Development
  • 11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Pharmaceutical and Biotech Companies
    • 11.7.2. Academic and Research Institutes
    • 11.7.3. Imaging Centers
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Modality
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Imaging Systems
    • 12.4.2. Reagents
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. Optical Imaging
    • 12.5.2. Nuclear Molecular Imaging
    • 12.5.3. Micro MRI
    • 12.5.4. Micro Ultrasound
    • 12.5.5. Micro CT
    • 12.5.6. Photoacoustic Tomography (PAT)
    • 12.5.7. Magnetic Particle Imaging
    • 12.5.8. Others
  • 12.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 12.6.1. Research & Development
    • 12.6.2. Drug Discovery & Development
  • 12.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Pharmaceutical and Biotech Companies
    • 12.7.2. Academic and Research Institutes
    • 12.7.3. Imaging Centers
    • 12.7.4. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Bruker
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Siemens Healthcare Private Limited
    • 13.3.3. Revvity
    • 13.3.4. FUJIFILM VisualSonics, Inc.
    • 13.3.5. Scintica
    • 13.3.6. MILabs B.V.
    • 13.3.7. United Imaging Healthcare Co., Ltd.
    • 13.3.8. Mediso Ltd.
    • 13.3.9. Aspect Imaging Ltd.
    • 13.3.10. Inviscan Imaging Systems
    • 13.3.11. TriFoil Imaging
    • 13.3.12. Southern Scientific Ltd.
    • 13.3.13. Iconeus
    • 13.3.14. MR Solutions
    • 13.3.15. BioPAL, Inc.
    • 13.3.16. Viscover

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations